SPALLONE, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 4.120
AS - Asia 848
EU - Europa 631
SA - Sud America 128
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.753
Nazione #
US - Stati Uniti d'America 4.094
SG - Singapore 394
CN - Cina 192
RU - Federazione Russa 132
BR - Brasile 102
VN - Vietnam 87
DE - Germania 86
IE - Irlanda 86
HK - Hong Kong 84
IT - Italia 80
UA - Ucraina 56
FR - Francia 44
GB - Regno Unito 40
SE - Svezia 37
FI - Finlandia 29
JP - Giappone 15
CA - Canada 14
IN - India 13
KR - Corea 11
TR - Turchia 9
MX - Messico 8
EG - Egitto 7
ID - Indonesia 7
ZA - Sudafrica 7
BD - Bangladesh 6
PL - Polonia 6
AT - Austria 5
EC - Ecuador 5
IQ - Iraq 5
PE - Perù 5
AR - Argentina 4
DK - Danimarca 4
ES - Italia 4
NL - Olanda 4
BE - Belgio 3
CL - Cile 3
KG - Kirghizistan 3
LT - Lituania 3
PK - Pakistan 3
RO - Romania 3
UY - Uruguay 3
VE - Venezuela 3
DZ - Algeria 2
EU - Europa 2
IL - Israele 2
MA - Marocco 2
PY - Paraguay 2
TH - Thailandia 2
UZ - Uzbekistan 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BJ - Benin 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CO - Colombia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TW - Taiwan 1
Totale 5.753
Città #
Houston 761
Wilmington 702
Woodbridge 619
Fairfield 265
Singapore 239
Chandler 227
Ashburn 193
Seattle 124
Ann Arbor 121
Cambridge 103
San Jose 90
Dublin 85
Hong Kong 84
New York 84
Beijing 82
Medford 63
Dearborn 57
Jacksonville 39
Santa Clara 37
Ho Chi Minh City 33
Los Angeles 31
The Dalles 30
Lawrence 29
Council Bluffs 25
Moscow 22
Munich 22
Lauterbourg 20
Helsinki 18
Rome 18
Hanoi 17
Buffalo 16
Tokyo 14
Dallas 13
San Diego 13
São Paulo 12
Boardman 11
Chicago 10
Nuremberg 10
Redwood City 10
Montreal 9
Orem 8
Shanghai 8
Turin 8
Zhengzhou 8
Ankara 7
Brooklyn 7
Chennai 7
Denver 7
Florence 7
London 7
Menlo Park 7
Norwalk 7
Poplar 7
Alexandria 6
Johannesburg 6
San Francisco 6
Da Nang 5
Falls Church 5
Guangzhou 5
Hefei 5
Jakarta 5
Lima 5
Milan 5
Mülheim 5
Stockholm 5
Belo Horizonte 4
Guarulhos 4
Haiphong 4
Jinan 4
Kunming 4
Mountain View 4
Nanjing 4
San Mateo 4
Seoul 4
Amsterdam 3
Bắc Giang 3
Casarile 3
Columbus 3
Elk Grove Village 3
Irecê 3
Lincoln 3
Manchester 3
Miami 3
Montevideo 3
Palo Alto 3
Paris 3
Querétaro 3
Redondo Beach 3
Romford 3
Suzhou 3
University Park 3
Warsaw 3
Wuhan 3
Allerød Municipality 2
Atlanta 2
Baoding 2
Biên Hòa 2
Brunflo 2
Campi Bisenzio 2
Chaoyang 2
Totale 4.623
Nome #
Leflunomide-induced DRESS syndrome 528
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 438
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 437
Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146 391
Prolonged survival of a patient with brain melanoma metastasis treated with BRAF and MEK inhibitors combination therapy 332
Image Gallery: Peculiar subungual localization of a second primary melanoma during BRAF inhibitors treatment for metastatic melanoma: case report 271
Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities 243
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias 214
Cutaneous mastocytosis: a dermatological perspective 201
Efalizumab 184
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 176
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers 175
High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature 170
Stem-Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients 166
Efficacy of Vismodegib in pigmented basal cell carcinoma: Appearances are deceiving 153
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas 150
Effects of short-term aerobic exercise in a mouse model of Niemann-Pick type C disease on synaptic and muscle plasticity 150
NF-κB, IκB Kinase and Interacting Signal Networks in Squamous Cell Carcinomas 147
Cancer duplicity: a case of chronic lymphocytic leukemia and metastatic melanoma treated with Ipilimumab 143
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab 139
A case of spontaneous regression of metastatic skin undifferentiated carcinoma 138
Patients with moderate to severe plaque psoriasis: One year after the European medicines agency recommendation of efalizumab suspension 131
Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis 123
HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis 118
Targeted therapy in nonmelanoma skin cancers 114
TRIM8 and p53: Making the right decision 106
Programmed cell death in the skin 101
Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis 90
Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis 84
Potential role of HLA-Cw6 in clinical response to anti-tumour necrosis factor alpha and t-cell targeting agents in psoriasis patients 57
Totale 5.870
Categoria #
all - tutte 19.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.009


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 0 36 29
2021/2022306 17 36 4 23 16 17 19 9 17 41 16 91
2022/2023452 49 47 23 60 45 107 24 28 46 0 16 7
2023/2024179 12 3 15 5 19 67 9 18 0 4 3 24
2024/2025605 43 118 79 49 13 41 48 24 68 36 36 50
2025/20261.121 91 84 140 137 113 52 162 127 125 90 0 0
Totale 5.870